|
Ranbaxy Laboratories is quite the rainmaker in India's pharmaceutical business. The company is India's largest drug manufacturer, as well as a top global generics producer. Anti-infectives amoxycillin and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also addresses gastrointestinal, musculoskeletal, and central nervous system disorders, as well as diabetes, pain, allergies, and HIV/AIDS. Its R&D focus includes new forms of existing drugs and metabolic disease treatments. The company also has a groundbreaking anti-malarial candidate in late-phase trials. Japanese drugmaker Daiichi Sankyo owns a controlling stake in Ranbaxy.
|
| | | Contact Information | |
Address: |
Plot 90, Sector 32
Gurgaon, Haryana 122001, India
| | Phone: | +91-124-513-5000 | | Fax: | +91-124-513-5001 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 943.60 M | | Employees (2008): | 12,174 |
|
|
Key People
| | • |
Chairman:
Tsutomu Une
| | • |
CEO and Managing Director:
Atul Sobti
| | • |
CFO:
Omesh Sethi
|
|
|
